These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18849657)

  • 1. Biophysical defects in voltage.gated sodium channels associated with long QT and Brugada syndromes.
    Jones DK; Ruben PC
    Channels (Austin); 2008; 2(2):70-80. PubMed ID: 18849657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome.
    Wang DW; Yazawa K; George AL; Bennett PB
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations.
    Remme CA; Wilde AA; Bezzina CR
    Trends Cardiovasc Med; 2008 Apr; 18(3):78-87. PubMed ID: 18436145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triggers for arrhythmogenesis in the Brugada and long QT 3 syndromes.
    Peters CH; Abdelsayed M; Ruben PC
    Prog Biophys Mol Biol; 2016 Jan; 120(1-3):77-88. PubMed ID: 26713557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes.
    Baroudi G; Chahine M
    FEBS Lett; 2000 Dec; 487(2):224-8. PubMed ID: 11150514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac sodium channelopathies.
    Amin AS; Asghari-Roodsari A; Tan HL
    Pflugers Arch; 2010 Jul; 460(2):223-37. PubMed ID: 20091048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCN5A channelopathies--an update on mutations and mechanisms.
    Zimmer T; Surber R
    Prog Biophys Mol Biol; 2008; 98(2-3):120-36. PubMed ID: 19027780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes.
    Rivolta I; Abriel H; Tateyama M; Liu H; Memmi M; Vardas P; Napolitano C; Priori SG; Kass RS
    J Biol Chem; 2001 Aug; 276(33):30623-30. PubMed ID: 11410597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na(+) channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism.
    Clancy CE; Rudy Y
    Circulation; 2002 Mar; 105(10):1208-13. PubMed ID: 11889015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential thermosensitivity in mixed syndrome cardiac sodium channel mutants.
    Abdelsayed M; Peters CH; Ruben PC
    J Physiol; 2015 Sep; 593(18):4201-23. PubMed ID: 26131924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models of SCN5A-related cardiac arrhythmias.
    Charpentier F; Bourgé A; Mérot J
    Prog Biophys Mol Biol; 2008; 98(2-3):230-7. PubMed ID: 19041666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel.
    Veldkamp MW; Viswanathan PC; Bezzina C; Baartscheer A; Wilde AA; Balser JR
    Circ Res; 2000 May; 86(9):E91-7. PubMed ID: 10807877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease.
    Zhang ZS; Tranquillo J; Neplioueva V; Bursac N; Grant AO
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H399-407. PubMed ID: 16877553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited sodium channelopathies: a continuum of channel dysfunction.
    Viswanathan PC; Balser JR
    Trends Cardiovasc Med; 2004 Jan; 14(1):28-35. PubMed ID: 14720472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics.
    Groenewegen WA; Bezzina CR; van Tintelen JP; Hoorntje TM; Mannens MM; Wilde AA; Jongsma HJ; Rook MB
    Cardiovasc Res; 2003 Mar; 57(4):1072-8. PubMed ID: 12650885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Channelopathy of voltage-gated sodium channel].
    Li YJ; Ji YH
    Sheng Li Ke Xue Jin Zhan; 1999 Oct; 30(4):297-302. PubMed ID: 12532821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium Channel Mutations in Cardiac Arrhythmia Syndromes.
    Betzenhauser MJ; Pitt GS; Antzelevitch C
    Curr Mol Pharmacol; 2015; 8(2):133-42. PubMed ID: 25981977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
    Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR
    J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.